Andy Pasternak - 13 Jan 2025 Form 4 Insider Report for Context Therapeutics Inc. (CNTX)

Role
Director
Signature
/s/ Alex Levit, Attorney-in-Fact
Issuer symbol
CNTX
Transactions as of
13 Jan 2025
Transactions value $
$0
Form type
4
Filing time
14 Jan 2025, 20:43:51 UTC
Previous filing
06 Oct 2023
Next filing
12 Jun 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNTX Stock Option (right to buy) Award $0 +20,685 $0.000000 20,685 13 Jan 2025 Common Stock 20,685 $1.03 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable on the earlier of (i) June 13, 2025 or (ii) the Issuer's 2025 annual meeting of stockholders, subject to continued service with the Issuer.